Filing Details
- Accession Number:
- 0001466049-10-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-05 12:00:00
- Reporting Period:
- 2009-12-31
- Filing Date:
- 2010-01-05
- Accepted Time:
- 2010-01-05 16:04:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1322505 | Biodel Inc | BIOD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1218154 | Scott Weisman | C/O Biodel Inc. 100 Saw Mill Road Danbury CT 06810 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2009-12-31 | 22,500 | $4.92 | 338,136 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2009.
- The amount does not include 107,873 shares held by The 1999 Weisman Family Trust, of which the undersigned and his spouse are trustees. The filing of this statement shall not be deemed an admission that the undersigned or his spouse is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of such shares.